Related Experiment Video
Updated: Apr 25, 2026

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Adult heart transplant: indications and outcomes
M Chadi Alraies1, Peter Eckman1
1Department of Medicine, Division of Cardiovascular Medicine, University of Minnesota, Minneapolis, MN, USA.
Insights
Cardiac transplantation improves survival for end-stage heart failure (HF) patients. Risk stratification and pre-transplant evaluation are crucial for selecting suitable candidates due to donor limitations and to optimize outcomes.
Area of Science:
- Cardiology
- Transplant Surgery
Background:
- Cardiac transplantation is the primary treatment for end-stage heart failure (HF) unresponsive to medical therapy.
- Improved survival and quality of life are observed in carefully selected heart transplant recipients.
Purpose of the Study:
- To review indications and pre-transplant evaluation for cardiac transplantation.
- To discuss risk stratification tools and contraindications for heart transplant candidacy.
- To summarize post-transplant outcomes and complications.
Main Methods:
- Review of current literature on cardiac transplantation indications, evaluation, and outcomes.
- Discussion of risk stratification models like the Heart Failure Survival Score (HFSS) and Seattle Heart Failure Model (SHFM).
Main Results:
- Risk stratification is essential for identifying optimal candidates due to limited donor availability.
- Pre-transplant evaluation includes exercise testing and assessment of contraindications.
- Key outcomes include survival rates and complications such as coronary allograft vasculopathy.
Conclusions:
- Cardiac transplantation offers significant benefits for selected end-stage HF patients.
- Thorough pre-transplant evaluation and risk stratification are critical for successful outcomes.
- Ongoing monitoring for complications like coronary allograft vasculopathy is necessary post-transplant.
Abstract:
Cardiac transplantation is the treatment of choice for many patients with end-stage heart failure (HF) who remain symptomatic despite optimal medical therapy. For carefully selected patients, heart transplantation offers markedly improved survival and quality of life. Risk stratification of the large group of patients with end-stage HF is essential for identifying patients who are most likely to benefit, particularly as the number of suitable donors is insufficient to meet demand. The indications for heart transplant and review components of the pre-transplant evaluation, including the role for exercise testing and risk scores such as the Heart Failure Survival Score (HFSS) and Seattle Heart Failure Model (SHFM) are summarized. Common contraindications are also discussed. Outcomes, including survival and common complications such as coronary allograft vasculopathy are reviewed.
Related Concept Videos
Kidney Transplant I: Introduction
Cardiomyopathy V: Interprofessional Care
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

